TI
IRON icon

Trexquant Investment’s Disc Medicine IRON Stock Holding History

Trexquant Investment’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,556
Closed -$425K – 1709
2025
Q1 		$425K Sell
8,556
-4,318
-34% -$240K ﹤0.01% 1322
2024
Q4 		$816K Sell
12,874
-3,201
-20% -$185K 0.01% 1157
2024
Q3 		$790K Sell
16,075
-2,526
-14% -$119K 0.01% 1125
2024
Q2 		$838K Buy
+18,601
New +$632K 0.01% 1064
2023
Q4 		– Sell
-12,534
Closed -$589K – 1600
2023
Q3 		$589K Buy
+12,534
New +$627K 0.01% 953

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trexquant Investment's IRON Position: Q2 2025 in Review

Trexquant Investment sold out of Disc Medicine (IRON) in Q2 2025, closing a stake of 8,556 shares — an estimated $425K sold.

Trexquant Investment first reported a position in IRON in Q3 2023 and held it in 5 quarters. The position peaked at $838K in Q2 2024. 151 funds tracked by Wall St. Rank hold IRON as of Q2 2025.

  • Trexquant Investment reported no remaining Disc Medicine position as of Q2 2025 after selling out during the quarter.
  • Trexquant Investment sold 8,556 Disc Medicine shares in Q2 2025, an estimated $425K.
  • Trexquant Investment first reported a position in Disc Medicine in Q3 2023 and held it in 5 quarters.
  • Trexquant Investment's Disc Medicine position peaked at $838K in Q2 2024.
  • 151 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2025.

Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.